J 2010

Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic

SZOTKOWSKI, Tomáš, Jan MUŽÍK, Jaroslava VOGLOVÁ, V. KOZA, J. MAALOUFOVA et. al.

Basic information

Original name

Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic

Authors

SZOTKOWSKI, Tomáš (203 Czech Republic, guarantor), Jan MUŽÍK (203 Czech Republic, belonging to the institution), Jaroslava VOGLOVÁ (203 Czech Republic), V. KOZA (203 Czech Republic), J. MAALOUFOVA (203 Czech Republic), Tomáš KOZÁK (203 Czech Republic), Marie JAROŠOVÁ (203 Czech Republic), Kyra MICHALOVÁ (203 Czech Republic), Pavel ŽÁK (203 Czech Republic), Kateřina STEINEROVÁ (203 Czech Republic), J. VYDRA (203 Czech Republic), M. LÁNSKÁ (203 Czech Republic), B. KATRINCSÁKOVÁ (203 Czech Republic), Kateřina SIČOVÁ (203 Czech Republic), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution) and Karel INDRÁK (203 Czech Republic, belonging to the institution)

Edition

Neoplasma, 2010, 0028-2685

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Slovakia

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.449

RIV identification code

RIV/00216224:14710/10:00051571

Organization unit

Institute of Biostatistics and Analyses

UT WoS

000286494400012

Keywords in English

Acute myeloid leukemia; prognostic factors; consolidation; stem cell transplantation; treatment outcome; registry

Tags

International impact, Reviewed
Změněno: 18/4/2012 10:38, RNDr. Tomáš Pavlík, Ph.D.

Abstract

V originále

Acute myeloid leukemia (AML) is a severe condition with a high mortality. When making decisions about the optimal tailor-made therapy, numerous prognostic factors are considered. The study represents a detailed analysis of the role of these factors and treatment outcomes based on a long-term follow-up of patients treated in 5 hematology intensive care centers in the Czech Republic.